Logo Università degli Studi di Milano


Department of

 
 

Drug repurposing of ERK inhibitors to target the transcription factor Nfix in dystrophic muscles: development of a new proof-of-concept study to hinder Muscular Dystrophies (1° anno)

Principal Investigators:
  • graziella MESSINA
Financing institution:
AFM-TELETHON - ASS. FRANCAISE CONTRE LES MYOPATHIES
Type:
INTLI - Finanziamenti internazionali
Project leader:
UNIVERSITA' DEGLI STUDI DI MILANO
Year:
2020
Duration:
12
Status:
APERTO
Back to top